For the OS univariate analysis, advanced age, the absence of CN and the presence of sarcomatoid features, bone metastasis, paraneoplastic symptoms, high CRP and high neutrophil to lymphocyte ratio (NLR) at the initiation of ipilimumab and nivolumab treatment were significantly correlated with short OS (Table 4). This evidence concerns the gene CRP and bone metastasis.